We are live on ! Find out more
PCM

Portolan Capital Management Portfolio holdings

AUM $2.67B
1-Year Est. Return 169.09%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+169.09%
3 Year Est. Return
+737.83%
5 Year Est. Return
+1,497.12%
10 Year Est. Return
+21,256.61%
AUM
$1.21B
AUM Growth
-$98.5M
Cap. Flow
-$79M
Cap. Flow %
-6.5%
Top 10 Hldgs %
27.39%
Holding
137
New
21
Increased
36
Reduced
59
Closed
20

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$12.6M
2
PHAT icon
Phathom Pharmaceuticals
PHAT
+$11.6M
3
TTMI icon
TTM Technologies
TTMI
+$11.5M
4
ORN icon
Orion Group Holdings
ORN
+$11.2M
5
MRVI icon
Maravai LifeSciences
MRVI
+$10.1M

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$19.2M
2
WKME
WalkMe Ltd. Ordinary Shares
WKME
+$19.1M
3
SG icon
Sweetgreen
SG
+$15.8M
4
UTHR icon
United Therapeutics
UTHR
+$14.8M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$14.1M

Sector Composition

Rank Sector Weight
1 Technology 33.79%
2 Healthcare 21.3%
3 Industrials 12.49%
4 Consumer Discretionary 8.15%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVI icon
26
Maravai LifeSciences
MRVI
$1.07B
$13.2M 1.09%
1,846,140
+1,165,684
+171% +$10.1M
CDMO
27
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$13M 1.07%
1,820,779
+953,894
+110% +$7.3M
SKX
28
DELISTED
Skechers
SKX
$12.7M 1.04%
183,190
-30,885
-14% -$2.04M
SG icon
29
Sweetgreen
SG
$827M
$12.7M 1.04%
419,875
-577,650
-58% -$15.8M
INDI icon
30
indie Semiconductor
INDI
$811M
$12.6M 1.04%
2,040,951
+196,965
+11% +$1.25M
DELL icon
31
Dell
DELL
$345B
$12.4M 1.02%
89,992
+30,423
+51% +$4.08M
CLBT icon
32
Cellebrite
CLBT
$2.88B
$12.2M 1%
1,020,952
-122,720
-11% -$1.37M
QNST icon
33
QuinStreet
QNST
$1.03B
$12.1M 1%
731,285
+370,680
+103% +$6.42M
ORN icon
34
Orion Group Holdings
ORN
$374M
$12.1M 0.99%
+1,267,822
New +$11.2M
META icon
35
Meta Platforms (Facebook)
META
$1.56T
$11.9M 0.98%
23,661
-1,764
-7% -$857K
RDDT icon
36
Reddit
RDDT
$28.7B
$11.9M 0.98%
+186,046
New +$9.81M
KRUS icon
37
Kura Sushi USA
KRUS
$539M
$11.9M 0.98%
187,875
+39,088
+26% +$3.94M
ARCT icon
38
Arcturus Therapeutics
ARCT
$444M
$11.8M 0.97%
484,907
+240,248
+98% +$7.29M
PHAT icon
39
Phathom Pharmaceuticals
PHAT
$763M
$11.6M 0.96%
+1,130,089
New +$11.6M
CELH icon
40
Celsius Holdings
CELH
$7.48B
$11.2M 0.92%
196,493
+97,231
+98% +$7.35M
AVAV icon
41
AeroVironment
AVAV
$7.56B
$11.2M 0.92%
61,280
+15,022
+32% +$2.7M
AEM icon
42
Agnico Eagle Mines
AEM
$102B
$11.1M 0.91%
169,030
-142,645
-46% -$9.31M
SMWB icon
43
Similarweb
SMWB
$740M
$10.6M 0.87%
1,367,259
-673,343
-33% -$5.24M
FLEX icon
44
Flex
FLEX
$42.2B
$10.5M 0.87%
356,839
-73,366
-17% -$2.2M
ORCL icon
45
Oracle
ORCL
$468B
$10.2M 0.84%
72,110
+19,797
+38% +$2.46M
PENG
46
Penguin Solutions Inc
PENG
$2.63B
$10.1M 0.83%
441,815
-251,241
-36% -$5.23M
NOG icon
47
Northern Oil and Gas
NOG
$2.74B
$9.93M 0.82%
267,170
-29,551
-10% -$1.19M
IESC icon
48
IES Holdings
IESC
$13.7B
$9.68M 0.8%
+138,910
New +$9.76M
PAYO icon
49
Payoneer
PAYO
$2.42B
$9.29M 0.77%
1,677,402
+465,085
+38% +$2.52M
CROX icon
50
Crocs
CROX
$5.48B
$9.25M 0.76%
63,373
-69,823
-52% -$9.79M
1
2
3 4 5

Similar funds

IAS
Insigneo Advisory Services Miami, Florida $2.67B AUM 40.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
BWFA
Baltimore-Washington Financial Advisors Columbia, Maryland $2.67B AUM 19.65% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
UPS
UHLMANN PRICE SECURITIES Skokie, Illinois $2.68B AUM 149.5% 1-Year Est. Return

Portolan Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Portolan Capital Management held 137 positions worth $1.21B, down 7.5% from $1.31B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Portolan Capital Management withdrew a net $79M in Q2 2024, closing 20 positions and reducing 59 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Portolan Capital Management opened a new position in Phathom Pharmaceuticals worth $11.6M.

  • Portolan Capital Management's largest Q2 2024 buy was Phathom Pharmaceuticals: 1,130,089 shares worth $11.6M.
  • Portolan Capital Management added most to Quanterix in Q2 2024, an estimated $12.6M increase.
  • Portolan Capital Management's biggest Q2 2024 reduction was Bio-Rad Laboratories Class A, cutting an estimated $19.2M.
  • Portolan Capital Management fully exited R1 RCM Inc. Common Stock in Q2 2024, selling an estimated $14.1M.
  • Portolan Capital Management's ten largest holdings make up 27% of its $1.21B portfolio in Q2 2024.
  • Portolan Capital Management opened 21 new positions and closed 20 in Q2 2024.
  • Portolan Capital Management's portfolio value fell 7.5% quarter-over-quarter to $1.21B.

Based on Portolan Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.